Antoine Vasseur et al.
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Oncogene 2024, vol. 43, issue 16
doi: 10.1038/s41388-024-02986-6